A lot of things need to go right on a molecular level for immune cells to launch an adaptive response to an infection. B ...

Building upon a deep understanding of immune cell activation, researchers from Children's Hospital of Philadelphia (CHOP) developed a new artificial platform that can be used to induce T cell ...

The inflammasome is a multiprotein complex that senses cellular stress and danger signals to initiate innate immune defences. Upon activation by pathogen-associated or damage-associated molecular ...

The experimental SchistoShield vaccine triggered strong B-cell and T-cell immune memory in early U.S. and African clinical trials.

Cellular responses that recognize and neutralize invading pathogens are an important part of survival and maintaining homeostasis—this is the basic principle of innate immunity [1]. Gnathostomes, or ...

Innate lymphoid cells, which curiously behave like T cells even though they don’t recognize specific antigens, show promise as a potential cancer therapeutic. In the years that followed, other groups ...

More and more routine vaccines are being linked to lower risks of dementia. Shots against seasonal flu, RSV, tetanus, diphtheria, and pertussis (Tdap), pneumococcal infections, hepatitis A and B, and ...

Dissecting protective versus detrimental immune responses uncovers biomarkers and mechanisms that can inform the rational design and evaluation of live attenuated vaccines against African swine fever ...

Adaptive Biotechnologies attracts attention as immune medicine innovation, diagnostic advancements, and biotechnology expansion continue to shape the healthcare sector.

Full-body defense does not always look the way textbooks say it should. In planarian flatworms, a newly identified cell type ...

Adaptive Biotechnologies (NASDAQ:ADPT) Chief Executive Officer and Co-Founder Chad Robins said the company is focused on expanding its minimal residual disease testing business while pursuing targeted ...